Table 1.
inhibitor | Ki(inact) (µM) | kinact (min−1) | kinact/Ki(inact) (µM–1 min−1) | IC50 (µM) |
---|---|---|---|---|
phenelzine | 5.6 ± 1.3 | 0.35 ± 0.056 | 0.063 ± 0.018 | N/A |
9a | N/A | N/A | N/A | 85.00 |
9b | N/A | N/A | N/A | >100.0 |
9c | 5.0 ± 1.1 | 0.32 ± 0.010 | 0.064 ± 0.014 | N/A |
9d | N/A | N/A | N/A | 46.74 |
9e | 8.0 ± 3.5 | 0.15 ± 0.023 | 0.019 ± 0.0087 | N/A |
9f | N/A | N/A | N/A | >100.0 |
9g | N/A | N/A | N/A | N/A |
9h | 22 ± 3.0 | 0.12 ± 0.01 | 0.0055 ± 0.00087 | N/A |
10a | 44 ± 9.7 | 0.15 ± 0.010 | 0.0034 ± 0.00079 | N/A |
10b | 12 ± 2.1 | 0.22 ± 0.020 | 0.018 ± 0.0036 | N/A |
11 | N/A | N/A | N/A | >100.0 |
12a | 0.28 ±0.11 | 0.19 ± 0.036 | 0.70 ± 0.31 | N/A |
12b | 0.37 ± 0.033 | 0.20 ± 0.0087 | 0.54 ± 0.054 | N/A |
12c | 0.26 ± 0.058 | 0.24 ± 0.022 | 0.92 ± 0.22 | N/A |
12d | 0.059 ± 0.021 | 0.15 ± 0.017 | 2.5 ± 0.96 | N/A |
12e | 0.26 ±0.11 | 0.22 ± 0.038 | 0.86 ± 0.39 | N/A |
12f | 0.156 ± 0.047 | 0.17 ± 0.018 | 1.1 ± 0.35 | N/A |
12g | 0.138 ± 0.0.48 | 0.17 ± 0.020 | 1.2 ± 0.44 | N/A |
12h | 0.207 ± 0.089 | 0.26 ± 0.042 | 1.2 ± 0.57 | N/A |
12i | 0.282 ± 0.076 | 0.21 ± 0.024 | 0.74 ± 0.22 | N/A |
12j | 0.204 ± 0.098 | 0.18 ± 0.034 | 0.88 ± 0.46 | N/A |
12k | 0.223 ± 0.064 | 0.17 ± 0.020 | 0.76 ± 0.24 | N/A |
121 | 2.0 ± 0.73 | 0.24 ± 0.033 | 0.12 ± 0.045 | N/A |
12m | 1.6 ± 0.49 | 0.22 ± 0.025 | 0.14 ± 0.044 | N/A |
13 | 0.10 ± 0.039 | 0.17 ± 0.21 | 1.7 ± 0.68 | N/A |
14 | 0.90 ± 0.45 | 0.18 ± 0.038 | 0.20 ± 0.11 | N/A |
15a | 0.21 ± 0.076 | 0.21 ± 0.030 | 1.0 ± 0.41 | N/A |
15b | 0.10 ± 0.035 | 0.17 ± 0.019 | 1.7 ± 0.60 | N/A |